Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:71 (14 January), doi:10.1136/bmj.332.7533.71
Abergavenny Roger Dobson
Incentive payments in the new NHS contract for primary care bear no relation to likely health benefits for their patients, concludes new research.
In some cases GPs will get paid more for treatments that save fewer lives than they will for treatments that achieve better results, say the authors of a study in the Journal of Health Services Research & Policy (2006:11:27-31).
Angiotensin converting enzyme (ACE) inhibitors for heart failure will save a maximum of 308 lives per 100 000 people in the population and attract a maximum practice payment of £2400 ($4240; €3510). Yet screening and treating hypertension, which will save a maximum of 71 lives per 100 000 people, carries a payment of £17 280.
The report says, "This finding suggests that there is a real danger the incentive payments may skew activity towards highly rewarded labour-intensive activities with relatively low benefits to population health.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?